Joint Hypermobility
12
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Regenerative Medicine for Joint Hypermobility and Instability
Hypermobility, Foot Posture, and Scoliosis Severity
Characteristics of the Functional State of the Musculoskeletal System, Body Awareness, and Quality of Life in Individuals With Joint Hypermobility, Their Associations, and Guidelines for Intervention.
Investigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema
Prenatal Hormonal Markers and Sleep Characteristics in Young Adults With Joint Hypermobility
Fitness Integrative Training for Pediatric Rheumatology Disorders
Functional Instability in Patients Suffering From Collagen Disease and Joint Hypermobility
The Effect of Lower Extremity Rotational Profile on Postural Control, Muscle Strength, Functional Capacity and Lower Extremity Function in Children With Generalized Joint Hypermobility
The Clinical Outcomes of the Modified Broström vs Anatomic Reconstruction Operation in CLAI and GJL
Muscle Strength and Balance in Individuals With Joint Hypermobility
The Clinical Outcomes of the Arthroscopic and Open Modified Broström Operation in CLAI and GJL
Gait Retraining in Patients With Joint Hypermobility Syndrome/Hypermobile Ehlers Danlos Syndrome